On October 5, 2023, an important study, published in JAMA and authored by Mohit Sodhi, indicated an increased risk of gastroparesis, bowel obstruction, and pancreatitis for those using GLP-1 agonists
Continued weekly subcutaneous semaglutide can help maintain weight loss and metabolic benefits, and this ongoing treatment is often necessary for long-term success
An estimated 2.5 billion adults were overweight in 2022, with approximately 890 million clinically obese a number that continues to rise annually
The same goes for non-prescription items advised by a physician alongside your medication
Heres a breakdown: If cost is a concern, switching could save you money especially if your insurance covers one medication but not the other
Strategies to overcome these drawbacks include increasing antigen size (for example, by fusing the RBD with an Fc domain 112,113,114,115,116 ) or by RBD multimerization (for example, by displaying multiple copies of RBD on particles 117,118,119 )